Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome

Lupus

Volumn 26, Issue 5, 2017, Pages 552-558

  Nalli, C ^a   Iodice, A ^b   Andreoli, L ^a   Galli, J ^a   Lojacono, A ^a   Motta, M ^c   Fazzi, E ^a   Tincani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

antiphospholipid syndrome (APS); behavioral disorders; children's outcome; learning disabilities; Systemic lupus erythematosus (SLE)

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN DEVELOPMENT; CHILD; CHILD BEHAVIOR CHECKLIST; CLINICAL ARTICLE; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE; LEARNING DISORDER; LOW DRUG DOSE; MALE; NEUROLOGIC EXAMINATION; NEUROLOGIST; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; THIRD TRIMESTER PREGNANCY; WECHSLER INTELLIGENCE SCALE; ADOLESCENT; COGNITIVE DYSFUNCTION; COMPLICATION; ETIOLOGY; IMMUNOLOGY; LEARNING DISORDERS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOLOGY;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHILD; CHILD, PRESCHOOL; COGNITIVE DYSFUNCTION; EPILEPSY; FEMALE; HUMANS; LEARNING DISORDERS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; WECHSLER SCALES;

EID: 85018283144     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203317694960     Document Type: Article

References (46)

1. Nalli C, Iodice A, Andreoli L, et al. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Lupus 2014; 23 (6): 507-517.
2. Vinet É Pineau CA, Clarke AE, Fombonne É Platt RW, Bernatsky S,. Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus. Lupus 2014; 23 (11): 1099-1104.
3. Lahita RG,. Systemic lupus erythematosus: Learning disabilities in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology 1988; 13: 385-396.
4. Ross G, Sammaritano L, Nass R, Lockshin M,. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003; 157: 397-402.
5. Neri F, Chimini L, Bonomi F, et al. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004; 13: 805-811.
6. Katzav A, Pick CG, Korczyn AD, et al. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 2001; 10 (7): 496-499.
7. Motta M, Chirico G, Rebaioli CB, et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: A follow-up study. Am J Perinatol 2006; 23 (4): 247-251.
8. Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 2013; 72: 217-222.
9. Urowitz MB, Gladman DD, MacKinnon A, et al. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus 2008; 17: 555-560.
10. Nacinovich R, Galli J, Bomba M, et al. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008; 59: 345-351.
11. Marder W, Ganser MA, Romero V, et al. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013; 65 (5): 759-766.
12. Brucato A, Astori MG, Cimaz R, et al. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis 2006; 65 (11): 1422-1426.
13. Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL,. Testing for antiphospholipid antibodies with solid phase assays: Guidance from the SSC of the ISTH. J Thromb Haemost 2014; 12 (5): 792-795.
14. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114 (5-6): 553-558.
15. Balestrieri G, Tincani A, Spatola L, et al. Anti-beta 2-glycoprotein I antibodies: A marker of antiphospholipid syndrome? Lupus 1995; 4 (2): 122-130.
16. A Orsini, L Picone (eds). WISC-III Wechsler Intelligence Scale for Children-III. Firenze: Giunti OS, 2006.
17. Cornoldi C,. Prove di Lettura MT-2 per la Scuola Primaria, Firenze: Organizzazioni Speciali, 2011.
18. Cornoldi C,. Test AC-MT 6-11 di valutazione delle abilità di calcolo, Trento (Italy): Erickson, 2002.
19. "Disturbi specifici dell'apprendimento". Documento di intesa, PARCC, 1 febbraio, 2011. Available at: www.lineeguidadsa.it.
20. Achenbach TM,. Child behavior checklist/4-18: Manual, Bosisio Parini (Italy): Editore Ghedini Libraio, 2001.
21. Lojacono A, Spatola L, Faden D, Tincani A, Balestrieri G,. Fetal stroke associated with maternal antiphospholipid antibodies: A case report. Lupus 1996; 5 (5): 512-512.
22. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE,. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol 2001; 144 (3): 523-532.
23. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM,. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol 2013; 133 (2): 377-385.
24. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR,. Incidence of epilepsy: A systematic review and meta-analysis. Neurology 2011; 77 (10): 1005-1012.
25. Abu-Arafeh I, Razak S, Sivaraman B, Graham C,. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev Med Child Neurol 2010; 52 (12): 1088-1097.
26. Meltzer LJ, Johnson C, Crosette J, Ramos M, Mindell JA,. Prevalence of diagnosed sleep disorders in pediatric primary care practices. Pediatrics 2010; 125 (6): e14108-e14108.
27. Brimberg L, Mader S, Jeganathan V, et al. Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice. Mol Psychiatry 2016; 21: 1663-1671.
28. Brimberg L, Sadiq A, Gregersen PK, Diamond B,. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry 2013; 18 (11): 1171-1177.
29. Brimberg L, Mader S, Fujieda Y, et al. Antibodies as mediators of brain pathology. Trends Immunol 2015; 36 (11): 709-724.
30. Piras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AM,. Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with autism spectrum disorder. Brain Behav Immun 2014; 38: 91-99.
31. Katzav A, Ben-Ziv T, Blank M, Pick CG, Shoenfeld Y, Chapman J,. Antibody-specific behavioral effects: Intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol 2014; 272 (1-2): 10-15.
32. Katzav A, Menachem A, Maggio N,. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. J Autoimmun 2014; 55: 86-93.
33. Frauenknecht K, Katzav A, Weiss Lavi R, et al. Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones. Neuropathol Appl Neurobiol 2015; 41 (5): 657-671.
34. Lee JY, Huerta PT, Zhang J, et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 2009; 15 (1): 91-96.
35. Chang EH, Volpe BT, Mackay M, et al. Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-aspartate receptor. EBioMedicine 2015; 2 (7): 755-764.
36. Marder W, Romero VC, Ganser MA, et al. Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies. Lupus Sci Med 2014; 1 (1): e000034-e000034.
37. Mocková A, UlA ová-Gallová Z, Náhlovský J, et al. Occurrence of selected antiphospholipid antibodies in offspring born from mothers with autoimmunity. Lupus 2012; 21 (7): 793-795.
38. Yoshikawa N, Tanaka K, Sekigawa M, et al. Neurodevelopment in the offspring of Japanese systemic lupus erythematosus patients. Brain Dev 2010; 32 (5): 390-395.
39. Vinet É Pineau CA, Clarke AE, et al. Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: Results from a large population-based cohort. Arthritis Rheumatol 2015; 67 (12): 3201-3208.
40. Sanna G, Bertolaccini ML, Hughes GR,. Hughes syndrome, the antiphospholipid syndrome: A new chapter in neurology. Review. Ann N Y Acad Sci 2005; 1051: 465-486.
41. Cimaz R, Romeo A, Scarano A, et al. Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 2002; 43 (1): 52-59.
42. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD,. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8 (2): 127-133.
43. Bomba M, Galli J, Nacinovich R, et al. Neuropsychiatric aid in children born to patients with rheumatic diseases. Clin exp Rheumatol 2010; 28 (5): 767-773.
44. Barkmann C, Romer G, Watson M, Schulte-Markwort M,. Parental physical illness as a risk for psychosocial maladjustment in children and adolescents: Epidemiological findings from a national survey in Germany. Psychosomatics 2007; 48 (6): 476-481.
45. Barbiero C, Lonciari I, Montico M, et al. The submerged dyslexia iceberg: How many school children are not diagnosed? Results from an Italian study. PLoS One 2012; 7 (10): e48082-e48082.
46. Bertolaccini ML, Contento G, Lennen R, et al. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun 2016; 75: 30-38.